在口腔癌中准补偿性扩散信号
Loganathan Kavitha1, Vijayashree Priyadharsini J2, Anitha P2
1Department of Oral and Maxillofacial Pathology, Ragas Dental College and Hospital (Affiliated to The Tamil Nadu Dr. MGR Medical University), ECR, Uthandi, Chennai-600119, India.
亡会触发癌细胞的增殖和耐药性,通过微粒细胞的治疗. 这些亡性细胞外微囊 (ApoEVs) 创造了一个利基,促进瘤生长,血管生成和转移,导致恶性瘤复发.
科学领域:
- 在瘤学瘤学.
- 细胞生物学 细胞生物学
- 癌症研究 癌症研究
背景情况:
- 细胞亡是一种调节的细胞死亡过程,对于维持组织平衡至关重要.
- 癌症涉及失调的细胞增殖和死亡,导致瘤生长.
- 癌症的治疗耐药性是一个主要的临床挑战,通常与瘤微环境适应有关.
研究的目的:
- 审查由亡诱导的增殖现象.
- 为了阐明细胞外微粒细胞 (ApoEVs) 在癌症中的作用.
- 讨论ApoEV如何促进治疗耐药性和恶性瘤复发.
主要方法:
- 文献综述侧重于亡,癌症生物学和细胞外囊泡.
- 分析ApoEVs影响瘤微环境的机制.
- 综合目前对ApoEVs在癌症进展和治疗耐药性方面的理解.
主要成果:
- 矛盾的是,亡可以刺激癌细胞的补偿增殖.
- 细胞外微粒细胞 (ApoEVs) 调解这种增殖反应.
- ApoEVs促进血管新生,免疫逃避,转移和入侵,建立一个瘤再生的利基.
结论:
- 由ApoEVs调解的亡诱导的扩散是癌症治疗耐药性的关键因素.
- ApoEVs有助于形成一个瘤再生利基,有利于瘤复发.
- 向ApoEV可能为克服恶性瘤治疗耐药性的新策略提供帮助.
更多相关视频
07:29Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment
Published on: April 22, 2019
06:11Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma
Published on: April 20, 2018
相关概念视频
Abnormal Proliferation
Targeted Cancer Therapies
There are several types of targeted therapies against...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Cancer Stem Cells and Tumor Maintenance
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
